MV, M., M, S., T, W., A, M., D, M., J, G., . . . DJ, O. (2022). Pharmacogenetic testing for NAT2 genotypes in a Tanzanian population across the lifespan to guide future personalized isoniazid dosing. Tuberculosis (Edinburgh, Scotland), 136, 102246. https://doi.org/10.1016/j.tube.2022.102246
Chicago Style (17th ed.) CitationMV, Masiphephethu, et al. "Pharmacogenetic Testing for NAT2 Genotypes in a Tanzanian Population Across the Lifespan to Guide Future Personalized Isoniazid Dosing." Tuberculosis (Edinburgh, Scotland) 136 (2022): 102246. https://doi.org/10.1016/j.tube.2022.102246.
MLA (9th ed.) CitationMV, Masiphephethu, et al. "Pharmacogenetic Testing for NAT2 Genotypes in a Tanzanian Population Across the Lifespan to Guide Future Personalized Isoniazid Dosing." Tuberculosis (Edinburgh, Scotland), vol. 136, 2022, p. 102246, https://doi.org/10.1016/j.tube.2022.102246.